Latest Hormonal contraception Stories
WAYNE, N.J., Jan. 9, 2013 /PRNewswire/ -- Bayer HealthCare Pharmaceuticals Inc. today announced that the U.S. Food and Drug Administration (FDA) approved Skyla((TM)) (levonorgestrel-releasing intrauterine system) 13.5 mg, a new hormone-releasing system that is placed in the uterus for the prevention of pregnancy for up to three years.[1] (Photo: http://photos.prnewswire.com/prnh/20130109/MM19804-a) (Photo: http://photos.prnewswire.com/prnh/20130109/MM19804-b) "Research shows...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) January 04, 2013 The prescription drug resource center DrugRisk.com is advising women who use the vaginal ring contraceptive NuvaRing that, amid warnings about risks of blood clots and news of injury claims filed by those affected, Merck has reported reduced sales of the devices. The goal of DrugRisk is...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com. New York, NY (PRWEB) January 01, 2013 The prescription drug resource center DrugRisk.com is announcing the most-searched topics in its comprehensive database of medication and medical device information for 2012. Among these is the popular birth control device NuvaRing. “DrugRisk’s goal is to improve patient safety by...
Consumers who have experienced blood clots from taking either Yaz or Yasmin are encouraged to contact the experienced Drug Side Effects Injury attorneys at McDonaldWorley.com to get assistance filing a claim. National law firm McDonaldWorley.com issues a settlement update. Houston, TX (PRWEB) December 28, 2012 Drug side effectsattorneys with national law firm of McDonaldWorley.com are now accepting new clients who have claims based on blood clots suffered alleged to result from taking the...
PITTSBURGH, Dec. 28, 2012 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today announced that its partner Famy Care Ltd. has received final approval from the U.S. Food and Drug Administration (FDA) for its Abbreviated New Drug Application (ANDA) for Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.15 mg/0.03 mg. This product is the generic version of Teva Branded Pharmaceutical Products' Nordette® 28 Tablets, which are indicated for the prevention of pregnancy in women who elect to use...
The US Drug Watchdog fears that most women have never heard of severe side effects associated with the birth control pills called Yaz, Yasmin, or their generic version Ocella, and they doubt most women would ever make the connection between a birth control pill, and a heart attack, a stroke, a pulmonary embolism, or blood clots. The US Drug Watchdog is urging women who used these specific types of birth control pills, and then developed a very serious medical condition to contact the...
The Drug Risk Resource Center is the Web’s largest source for information on medical device research, side effects and legal news. Visit http://www.DrugRisk.com New York, NY (PRWEB) December 22, 2012 Prescription drug resource center DrugRisk.com is alerting patients using Mirena IUDs that it has added information about litigation surrounding the devices to its comprehensive database, including a recently-filed lawsuit in which a woman alleges she suffered physical injury from device...
The Drug Risk Resource Center is the Web’s largest source for information on prescription drug warnings, side effects and legal news. Visit http://www.DrugRisk.com. Dallas, TX (PRWEB) December 21, 2012 The prescription drug resource center DrugRisk.com is advising patients concerned over their options following a NuvaRing side effect that the recent delay of trials could help with resolution of litigation. DrugRisk seeks to improve patient safety through education of the latest drug...
The Drug Risk Resource Center is the Web’s largest source for information on medical device research, side effects and legal news. Visit http://www.DrugRisk.com Orlando, FL (PRWEB) December 19, 2012 Earlier this month, Bayer announced it would enter the European market with a new plastic contraceptive implant that can provide birth control for up to three years. The Jaydess device, which was recently approved by the EMA, also faces a decision from the FDA in the U.S. sometime in 2013.*...
Several studies have linked the newer types of birth control, which contain a man-made hormone known as drospirenone, with a higher risk of potentially fatal blood clots among women. San Antonio, TX (PRWEB) December 16, 2012 Yaz, Yasmin and Ocella injury lawyers today said a study published in the Canadian Medical Association Journal on Dec. 3 raises some alarming concerns about the birth control blood clot risk. According to a Dec. 3, 2012, report in the Reuters about the study, women...
